Jupiter Neurosciences Valuation Multiples

Jupiter Neurosciences Overview

About Jupiter Neurosciences

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Founded

2016

HQ

Employees

13

Website

jupiterneurosciences.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: —

EBITDA: ($2M)

EV

$15M

Valuation Multiples

Multiples.vc

Start free trial

Jupiter Neurosciences Financials

Jupiter Neurosciences reported last fiscal year revenue of — and negative EBITDA of ($2M).

In the same fiscal year, Jupiter Neurosciences generated ($2M) in EBITDA losses and had net loss of ($2M).

Jupiter Neurosciences P&L

In the most recent fiscal year, Jupiter Neurosciences reported revenue of — and EBITDA of ($2M).

Jupiter Neurosciences expects next 12-month revenue of XXX and NTM EBITDA of XXX

Jupiter Neurosciences Stock Performance

Jupiter Neurosciences has current market cap of $16M, and enterprise value of $15M.

Jupiter Neurosciences' stock price is $0.45.

Jupiter Neurosciences Valuation Multiples

Jupiter Neurosciences trades at (6.9x) EV/EBITDA.

Jupiter Neurosciences Financial Valuation Multiples

As of April 2, 2026, Jupiter Neurosciences has market cap of $16M and EV of $15M.

Equity research analysts estimate Jupiter Neurosciences' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Jupiter Neurosciences has a P/E ratio of (6.4x).

Jupiter Neurosciences Margins & Growth Rates

Jupiter Neurosciences' revenue in the last fiscal year grew by —.

Jupiter Neurosciences' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.

Jupiter Neurosciences Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Jupiter Neurosciences M&A Activity

Jupiter Neurosciences acquired XXX companies to date.

Last acquisition by Jupiter Neurosciences was on XXXXXXXX, XXXXX. Jupiter Neurosciences acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Jupiter Neurosciences Investment Activity

Jupiter Neurosciences invested in XXX companies to date.

Jupiter Neurosciences made its latest investment on XXXXXXXX, XXXXX. Jupiter Neurosciences invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).